JP2011529946A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529946A5
JP2011529946A5 JP2011521575A JP2011521575A JP2011529946A5 JP 2011529946 A5 JP2011529946 A5 JP 2011529946A5 JP 2011521575 A JP2011521575 A JP 2011521575A JP 2011521575 A JP2011521575 A JP 2011521575A JP 2011529946 A5 JP2011529946 A5 JP 2011529946A5
Authority
JP
Japan
Prior art keywords
particles
active ingredient
diameter
growth factor
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011521575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529946A (ja
JP5623400B2 (ja
Filing date
Publication date
Priority claimed from GBGB0814302.6A external-priority patent/GB0814302D0/en
Application filed filed Critical
Publication of JP2011529946A publication Critical patent/JP2011529946A/ja
Publication of JP2011529946A5 publication Critical patent/JP2011529946A5/ja
Application granted granted Critical
Publication of JP5623400B2 publication Critical patent/JP5623400B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011521575A 2008-08-05 2009-08-05 直径10〜20μmのマイクロスフェアを含む非経口組成物 Expired - Fee Related JP5623400B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0814302.6A GB0814302D0 (en) 2008-08-05 2008-08-05 Compounds and methods
GB0814302.6 2008-08-05
PCT/EP2009/060171 WO2010015665A2 (en) 2008-08-05 2009-08-05 Compounds and methods

Publications (3)

Publication Number Publication Date
JP2011529946A JP2011529946A (ja) 2011-12-15
JP2011529946A5 true JP2011529946A5 (enExample) 2012-08-30
JP5623400B2 JP5623400B2 (ja) 2014-11-12

Family

ID=39846672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521575A Expired - Fee Related JP5623400B2 (ja) 2008-08-05 2009-08-05 直径10〜20μmのマイクロスフェアを含む非経口組成物

Country Status (13)

Country Link
US (3) US20120195939A1 (enExample)
EP (1) EP2323626B1 (enExample)
JP (1) JP5623400B2 (enExample)
KR (1) KR101639827B1 (enExample)
CN (1) CN102170868A (enExample)
AU (1) AU2009279086B2 (enExample)
BR (1) BRPI0917571B1 (enExample)
CA (1) CA2732785C (enExample)
CL (1) CL2011000244A1 (enExample)
ES (1) ES2677005T3 (enExample)
GB (1) GB0814302D0 (enExample)
MX (1) MX2011001261A (enExample)
WO (1) WO2010015665A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
US10195252B2 (en) 2012-08-03 2019-02-05 University of Pittsburgh—of the Commonwealth System of Higher Education Recruitment of mensenchymal cells using controlled release systems
US9828603B2 (en) 2012-08-13 2017-11-28 Cedars Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
WO2014066545A1 (en) * 2012-10-26 2014-05-01 Cedars-Sinai Medical Center Therapeutic cells depleted of specific subpopulations of cells for use in tissue repair of regeneration
US10526581B2 (en) * 2013-01-24 2020-01-07 Bernardo Nadal-Ginard Modulation of cardiac stem-progenitor cell differentiation, assays and uses thereof
EP2759595B1 (en) * 2013-01-24 2016-09-14 Pierre Fabre Médicament S.A.S. Composition comprising an encapsulated antagomir
US11357799B2 (en) 2014-10-03 2022-06-14 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
CN104650333B (zh) * 2015-02-05 2016-08-24 浙江大学 聚乳酸/氢化聚丁二烯热塑性超分子弹性体及其制备方法
PL3264997T3 (pl) * 2015-03-02 2019-07-31 Accurate Medical Therapeutics Ltd. Cewniki z otworami bocznymi do modyfikowania i podawania zawiesin pacjentowi
JP6743041B2 (ja) 2015-03-30 2020-08-19 タリス バイオメディカル エルエルシー 上部尿路への薬剤の局所的な送達装置及び方法
EP3402543B1 (en) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
CN109414266B (zh) 2016-05-04 2021-07-23 阿克瑞特医学治疗有限公司 具有狭缝状图案的栓塞微导管头部
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
WO2017220611A1 (en) 2016-06-20 2017-12-28 Virbac Oral pharmaceutical composition comprising a pharmaceutically active agent, at least one cationic bioadhesive polymer and at least two anionic polymers
EP3515459A4 (en) 2016-09-20 2020-08-05 Cedars-Sinai Medical Center CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
CN111447882B (zh) 2017-11-02 2024-05-24 阿克瑞特医学治疗有限公司 具有一体式过滤器的栓塞导管
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
EP3737415A4 (en) * 2018-01-12 2021-06-30 President and Fellows of Harvard College COMPOSITIONS AND PROCEDURES RELATED TO MACROPHAGE AND / OR MONOCYTE WITH ATTACHED PARTICLES
EP3749344A4 (en) 2018-02-05 2022-01-26 Cedars-Sinai Medical Center METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS
BR112021023510A2 (pt) 2019-05-23 2022-01-18 Accurate Medical Therapeutics Ltd Cateter de embolização para distribuição livre de refluxo de microesferas.
EP4281044A1 (en) * 2021-01-22 2023-11-29 University of Connecticut Synthetic artificial stem cells (sasc)
CN121099998A (zh) * 2023-02-02 2025-12-09 银溪制药股份有限公司 使用igf-1嵌合蛋白的治疗方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
CN1175208A (zh) * 1994-12-16 1998-03-04 安达里斯有限公司 交联的微粒及其作为治疗载体的用途
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
CA2161863A1 (en) 1995-10-31 1997-05-01 Michael Vivian Sefton Angiogenic material and uses thereof
US6511477B2 (en) 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
WO1998047532A1 (en) 1997-04-24 1998-10-29 Nycomed Imaging As Embolus therapy using insoluble microparticles or vesicles containing contrast agents
ATE220564T1 (de) 1997-08-14 2002-08-15 Sulzer Innotec Ag Zusammensetzung und vorrichtung zur reparatur von knorpelgewebe in vivo bestehend aus nanokapseln mit osteoinduktiven und/oder chondroinduktiven faktoren
ATE233097T1 (de) * 1997-11-07 2003-03-15 Chiron Corp Verfahren zur herstellung von igf-i formulierungen mit verzögerter freisetzung
AU6411199A (en) 1998-10-13 2000-05-01 Chiron Corporation Angiogenically effective unit dose of fgf and method of administering
JP2003516926A (ja) 1998-11-18 2003-05-20 ユニバーシティ オブ フロリダ コーティングされた薬物粒子及びその薬学的製剤を調製するための方法
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2003059375A1 (en) * 2002-01-17 2003-07-24 Cardio Incorporated Complex therapy for tissue regeneration
US20030199464A1 (en) 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
NZ539166A (en) * 2002-09-05 2008-03-28 Univ Wm Marsh Rice A controlled release device comprising antibiotic microspheres for treatment of infections and osteomyelitis
WO2004084819A2 (en) * 2003-03-19 2004-10-07 University Of Kentucky Research Foundation Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
CA2819769C (en) * 2003-07-18 2016-06-28 Oakwood Laboratories, L.L.C. Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
JP4532092B2 (ja) * 2003-09-30 2010-08-25 泰彦 田畑 血管新生剤
US20070116768A1 (en) 2003-12-09 2007-05-24 Michael Chorny Sustained release preparations composed of biocompatible complex microparticles
WO2005094888A1 (ja) * 2004-03-31 2005-10-13 Two Cells Co. Ltd. 損傷組織の治療剤と治療方法
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
ES2273572B1 (es) * 2005-05-04 2008-04-01 Universidad De Sevilla Procedimiento de preparacion de particulas de tamaño micro y nanometrico con productos labiles y particulas obtenidas.
WO2007028053A2 (en) 2005-09-02 2007-03-08 X-Cell Medical Incorporated Methods of treating and preventing cardiac disorders
KR100718329B1 (ko) 2005-09-08 2007-05-14 광주과학기술원 다당류로 기능화된 수화젤막을 가지는 나노입자와 이를포함하는 서방형 약물전달시스템 및 그 제조방법
US8506965B2 (en) * 2005-11-11 2013-08-13 Vascular Biosciences R-RAS activity in vascular regulation
CN101563097A (zh) * 2005-11-14 2009-10-21 企业合伙人风险资本公司 用于组织损伤的干细胞生长因子疗法
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
ES2459743T3 (es) 2006-10-19 2014-05-12 Ono Pharmaceutical Co., Ltd. Preparación de liberación sostenida para terapia de regeneración tisular
WO2008108736A1 (en) 2007-03-06 2008-09-12 Agency For Science, Technology And Research Particles for delivery of bioactive factors
EP2244697A1 (en) 2008-01-29 2010-11-03 Shire Human Genetic Therapies, Inc. Therapeutic compositions
WO2009100128A1 (en) 2008-02-04 2009-08-13 Massachusetts Institute Of Technology Particulate delivery vehicles for embryoid bodies
US20090297621A1 (en) * 2008-06-03 2009-12-03 Abbott Cardiovascular Systems Inc. Microparticles For The Treatment Of Disease
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods

Similar Documents

Publication Publication Date Title
JP2011529946A5 (enExample)
Bakhshandeh et al. Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues
Lee et al. The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration
Yang et al. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor
US6596296B1 (en) Drug releasing biodegradable fiber implant
Batista et al. Alginate: pharmaceutical and medical applications
US8062654B2 (en) Drug releasing biodegradable fiber for delivery of therapeutics
US20110268776A1 (en) Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
Patel et al. Potential application of PLGA microsphere for tissue engineering
WO2009131752A2 (en) Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
Zhao et al. Research advances in tissue engineering materials for sustained release of growth factors
Ou et al. Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model
Wang et al. Electrospun multifunctional tissue engineering scaffolds
CN105407931A (zh) 伤口敷料及其应用
KR20130019150A (ko) 생리활성물질 함유 미세입자를 포함하는 약물전달계가 고정화된 고분자 생체 재료의 제조방법
CN102711798A (zh) 刺激干细胞的药物组合物
CN102170868A (zh) 包含介于10和20微米之间直径的微球的胃肠外给药组合物
Karim Haidar et al. Nanofibers: new insights for drug delivery and tissue engineering
US20240366734A1 (en) Pharmaceutical composition for treating keloid and uses thereof
Shen et al. Growth factor loading on aliphatic polyester scaffolds
JP2013512877A5 (enExample)
WO2018000082A2 (en) Encapsulation-free controlled protein release system
JP2018537158A (ja) 骨修復における骨誘導性分子の送達増強のためのマトリックス
Hu et al. Fabrication and characterization of a multi-functional GBR membrane of gelatin-chitosan for osteogenesis and angiogenesis
Esteban-Garcia et al. Neurorestoration approach by biomaterials in ischemic stroke